Page last updated: 2024-08-21

chenodeoxycholic acid and Alzheimer Disease

chenodeoxycholic acid has been researched along with Alzheimer Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Q; Gai, Z; Gui, T; Guo, X; Liu, J; Ma, H	1

Other Studies

1 other study(ies) available for chenodeoxycholic acid and Alzheimer Disease

Article	Year
Farnesoid X Receptor (FXR) Aggravates Amyloid-β-Triggered Apoptosis by Modulating the cAMP-Response Element-Binding Protein (CREB)/Brain-Derived Neurotrophic Factor (BDNF) Pathway In Vitro. Medical science monitor : international medical journal of experimental and clinical research, 2019, Dec-08, Volume: 25 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Brain; Brain-Derived Neurotrophic Factor; Cell Line; Chenodeoxycholic Acid; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Hippocampus; Humans; Mice; Neurons; Receptors, Cytoplasmic and Nuclear; Signal Transduction	2019

Article

Year

Farnesoid X Receptor (FXR) Aggravates Amyloid-β-Triggered Apoptosis by Modulating the cAMP-Response Element-Binding Protein (CREB)/Brain-Derived Neurotrophic Factor (BDNF) Pathway In Vitro.

Medical science monitor : international medical journal of experimental and clinical research, 2019, Dec-08, Volume: 25

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Brain; Brain-Derived Neurotrophic Factor; Cell Line; Chenodeoxycholic Acid; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Hippocampus; Humans; Mice; Neurons; Receptors, Cytoplasmic and Nuclear; Signal Transduction

2019